QUEBEC CITY, April 30 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, announced today that it will hold its Annual Shareholder Meeting on Wednesday, May 2, 2007 starting at 10:30 a.m. Eastern, in the Drummond Room of the Sheraton Centre, 1201 Rene-Levesque West, in Montreal. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor Relations & Corporate Communications, (418) 655-6420, ; Paul Burroughs, Media Relations, (418) 652-8525, ext. 406,

Copyright